BILL Q1 2026 Earnings EPS Surpasses Estimates by Nearly 20 on Operational Discipline MTVA Q1 2026 Earnings EPS Misses Estimates but Stock Surges 3415 Vistagen Therapeutics VTGN Q1 2026 Earnings Narrowing Loss Beats Estimates as Pipeline Progress Continues ELTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Advances Pipeline Without Revenue Tenable Holdings Q1 2026 Earnings EPS Surprises Positively Revenue Detail Not Disclosed TSHA Q1 2026 Earnings EPS Miss Highlights Ongoing DevelopmentStage Challenges